The Biomarkers That Predict How You Age

Aging is not a single event, and it is not captured by a single number. It reflects gradual changes across multiple interconnected systems—metabolic, cardiovascular, hormonal, musculoskeletal, inflammatory, and others—that unfold differently from one person to the next.

Many of the factors associated with future disease and functional decline can be measured before someone feels unwell. That creates an important opportunity: not to predict the future with certainty, but to identify risk earlier, establish meaningful baselines, and intervene where doing so is supported by evidence.

That is the premise of a data-driven approach to healthspan.

But the value is not in collecting the most data. It is in collecting the right data and knowing what it means.

At Metriq Health, we think of biomarkers as pieces of a larger clinical picture. A laboratory result can help reveal what is happening physiologically, but it cannot be interpreted responsibly without considering age, symptoms, medical and family history, medications, lifestyle, physical findings, and how the value is changing over time.

A number without context is just a number.

Why “Normal” Isn’t the Whole Story

Most laboratory results are reported alongside a reference interval. That interval is generally derived from values observed in a defined reference population and helps clinicians identify results that are unusual.

But a laboratory reference interval is not necessarily the same thing as a treatment threshold, a risk threshold, or the appropriate target for a particular patient.

That distinction matters.

For some biomarkers, strong clinical evidence has established thresholds associated with increased disease risk or criteria used for diagnosis. For others, the significance of a result depends heavily on the patient’s broader clinical context. And even when a value remains within a reference interval, a meaningful change over time may warrant attention.

There are other reasons not to overinterpret a single result. Biomarkers can fluctuate because of hydration, time of day, recent exercise, illness, medications, laboratory variability, and normal biological variation.

That is why sophisticated interpretation is more important than simply labeling a result “normal” or “abnormal.”

Two people with the same laboratory value may have very different risk profiles—and the same value can mean something different in one person at age 35 than it does in another at age 65.

When appropriate, trends are often more informative than snapshots.

Your biomarkers should be read more like a movie than a photograph.

The Biomarkers That Matter Most for Healthspan

There is no universal “longevity panel,” and there should not be.

The goal is not to order every available test. It is to identify the measurements most likely to clarify an individual’s health, risk, physiology, and opportunities for intervention.

Several categories are particularly useful.

Metabolic Markers

Metabolic dysfunction can develop gradually, often well before type 2 diabetes is diagnosed.

Fasting glucose and hemoglobin A1c are established measures used to evaluate glycemic health and diagnose prediabetes and diabetes. They provide different but complementary information: fasting glucose reflects glucose regulation at a particular point in time, while A1c estimates average glycemic exposure over the preceding several months. Current American Diabetes Association standards continue to use A1c and plasma-glucose criteria as the principal diagnostic measures for diabetes.

Triglycerides, HDL cholesterol, blood pressure, waist or body-composition measures, and other clinical findings can add important information about cardiometabolic health.

In selected patients, fasting insulin may provide additional context about insulin dynamics, but it should not be treated as a stand-alone diagnostic test for insulin resistance. The clinical question matters more than the size of the panel.

The objective is to recognize meaningful metabolic risk early enough to act on it through nutrition, physical activity, body-composition improvement, sleep, medication when appropriate, and other evidence-based interventions.

Hormonal and Endocrine Markers

Hormonal health deserves thoughtful evaluation—but hormones should not be treated as generic “longevity scores.”

Thyroid hormones, sex hormones, and other endocrine markers can be highly informative when evaluated for the right clinical reason. Their interpretation should be guided by symptoms, age, reproductive or menopausal stage, medical history, medications, and the specific hormone being measured.

For example, a hormone concentration that is relevant to a symptomatic patient may have little clinical significance in an asymptomatic person simply because it falls toward one end of a laboratory range.

At Metriq Health, the objective is not to chase a theoretically “perfect” hormone number.

It is to determine whether hormonal physiology is contributing to meaningful symptoms or health concerns—and, when treatment is clinically appropriate, to assess both response and safety over time.

Cardiovascular Risk Markers

Cardiovascular disease is a major cause of premature illness, disability, and loss of healthspan, making cardiovascular risk assessment one of the most important components of long-term health optimization.

A standard lipid profile remains foundational, but it does not tell the entire story.

Depending on the individual, additional measures may refine risk. Apolipoprotein B (ApoB) reflects the number of atherogenic lipoprotein particles and can be particularly useful when residual lipoprotein-related risk may not be apparent from a conventional lipid profile alone. The 2026 ACC/AHA dyslipidemia guideline specifically identifies ApoB as useful in selected patients, including some individuals with elevated triglycerides, diabetes, or low achieved LDL cholesterol.

Lipoprotein(a), or Lp(a), is another important marker. Lp(a) is largely genetically determined and can confer cardiovascular risk that is not evident from LDL cholesterol alone. Importantly, updated 2026 ACC/AHA guidance recommends measuring Lp(a) at least once in adulthood to identify individuals with elevated risk.

And sometimes the most informative next step is not another blood test. In appropriately selected adults, coronary artery calcium (CAC) scoring can help detect subclinical coronary atherosclerosis and refine cardiovascular risk when treatment decisions remain uncertain. CAC is measured with a quick, noninvasive CT scan of the heart that quantifies calcified plaque in the coronary arteries. The updated guideline recommends selective—not indiscriminate—use of CAC for risk reclassification.

This distinction is central to our philosophy: advanced testing is valuable when it has the potential to change clinical understanding or management—not simply because the technology exists.

Inflammatory and Nutritional Markers

Inflammation is involved in many chronic disease processes, but “inflammation” is also one of the most loosely used concepts in wellness medicine.

High-sensitivity C-reactive protein, or hsCRP, can provide useful information about systemic inflammation and, in appropriate settings, can contribute to cardiovascular risk assessment. But hsCRP is nonspecific. Infection, injury, inflammatory conditions, and other temporary factors can raise it, which means an isolated elevation should be interpreted in context rather than treated as evidence of a single underlying problem. Current cardiovascular guidance includes hsCRP among the additional measures that may help refine ASCVD risk in appropriate individuals.

Nutritional biomarkers can also be useful, but testing should be purposeful. Vitamin B12, vitamin D, iron indices, and other nutrient measures may be clinically important when symptoms, dietary patterns, medications, medical conditions, or other risk factors create a reasonable concern for deficiency or excess.

The goal is not to screen indiscriminately for dozens of nutrients. It is to ask a clinical question and order the test most capable of answering it.

Body Composition and Musculoskeletal Health

Weight alone tells relatively little about how the body is changing with age.

Two people can weigh exactly the same and have dramatically different proportions of skeletal muscle and adipose tissue—and therefore very different metabolic and functional profiles.

That is why measures such as lean mass, fat mass, visceral adiposity, and bone mineral density can provide information that weight and BMI cannot capture alone. These can be assessed with tools such as a DEXA scan, which provides a detailed picture of body composition and bone density beyond what the scale can show.

Preserving muscle becomes increasingly important with age because skeletal muscle contributes not only to strength and mobility, but also to metabolic health and the ability to remain physically independent. Bone health is similarly important because loss of bone density can remain clinically silent until fracture occurs.

For the right patient, objective body-composition and bone assessment can establish a useful baseline and make it possible to determine whether an intervention is producing the intended change.

Cardiorespiratory Fitness and Functional Capacity

Not every important healthspan measure comes from a blood draw.

Cardiorespiratory fitness—often quantified through VO₂ max or related measures—is one of the most informative objective assessments of physical capacity and long-term health.

It reflects the integrated ability of the cardiovascular, respiratory, circulatory, and muscular systems to deliver and use oxygen during physical activity. Higher cardiorespiratory fitness is strongly associated with lower cardiovascular and all-cause mortality risk, which led the American Heart Association to argue that cardiorespiratory fitness deserves consideration as a clinical “vital sign.”

This is an important distinction in healthspan medicine.

Someone can exercise regularly and still benefit from understanding their actual physiologic capacity. Objective fitness testing provides a baseline, identifies an opportunity for improvement, and makes it possible to determine whether training is meaningfully changing performance over time.

The same principle applies to other functional measures: healthspan is ultimately about what the body can do, not simply what appears on a laboratory report.

Where Supplements Fit—and Where They Don’t

Supplements are one of the most common questions in health optimization—and one of the areas most vulnerable to overpromising.

Our approach is straightforward: supplementation should have a reason.

That reason may be a demonstrated nutritional deficiency, a medical condition or medication that increases risk of deficiency, a clearly established preventive indication, or another evidence-based clinical rationale.

What we do not believe in is assuming that taking more supplements necessarily produces better health.

It does not.

Nutrients can have dose-dependent effects, supplements can interact with medications, and correcting a deficiency is fundamentally different from pushing a nutrient concentration beyond what is physiologically necessary. Large supplement stacks can also create cost and complexity without demonstrating meaningful benefit.

For many commonly used supplements, evidence for preventing chronic disease in otherwise well-nourished adults remains limited; for example, large randomized trials of multivitamin/mineral supplementation have not demonstrated reductions in major cardiovascular events.

When a supplement is indicated, measurement may sometimes help establish the need, guide treatment, and determine whether the intervention is accomplishing what was intended.

Again, the principle is simple:

Test when testing will inform a decision. Treat when there is a defensible reason. Reassess when reassessment will change what comes next.

From Data to a Plan

Measurement is only the beginning.

The real value of a biomarker—or any health measure—is its ability to improve a decision.

That requires distinguishing meaningful signal from noise, understanding which risks deserve priority, determining what is modifiable, and choosing interventions with a reasonable likelihood of improving an outcome that matters.

At Metriq Health, the process is deliberately iterative:

Measure. Interpret. Prioritize. Intervene. Reassess. Refine.

Sometimes the right action is medication. Sometimes it is a change in nutrition, exercise, sleep, or body composition. Sometimes it is hormone therapy when clinically indicated. Sometimes it is additional evaluation or referral to another specialist.

And sometimes the right response to a result is simply to watch it.

That matters because health optimization should not become the indiscriminate medicalization of every imperfect number.

Our goal is not to produce the largest possible dataset or move every biomarker toward an arbitrary definition of “optimal.”

It is to identify the information that matters, understand what it means for the individual patient, and translate it into thoughtful action.

Through Metriq Optimize membership, patients receive ongoing, physician-guided care so that data can be interpreted longitudinally rather than as a series of disconnected snapshots. As physiology, goals, treatments, and circumstances change, the plan can evolve with them.

A Physician-Led Approach in the Conejo Valley

For patients throughout the greater Los Angeles and Conejo Valley region—including Thousand Oaks, Westlake Village, Agoura Hills, and Calabasas—Metriq Health provides comprehensive, physician-led evaluation as part of a broader approach to healthspan, hormone health, and metabolic optimization.

Our philosophy is simple: measure what matters, understand what it means, and act where action is justified.

We do not treat numbers in isolation. We do not chase every new test because it has been labeled “advanced.” And we do not confuse more data with better medicine.

Instead, we integrate objective measurement with symptoms, history, goals, clinical judgment, and longitudinal follow-up to develop a more complete understanding of health—and a more thoughtful plan for improving it.

Because the goal of health optimization is not a perfect laboratory report.

It is better health, better function, and more years spent capable of living the life you want to live.

Schedule a consultation with Metriq Health to learn more about biomarker evaluation and healthspan optimization.

By Eileen M. Higham, PhD
Co-Founder and Chief Executive Officer, Metriq Health

Educational content. Individual results may vary. This article is not a substitute for individualized medical advice, diagnosis, or treatment. Testing and treatment decisions should be made in consultation with a qualified physician based on your individual medical history and health status.